TRIB Share Price

Open 5.30 Change Price %
High 5.53 1 Day 0.15 2.84
Low 5.25 1 Week 0.14 2.64
Close 5.44 1 Month -0.04 -0.73
Volume 32758 1 Year -5.79 -51.56
52 Week High 13.68
52 Week Low 5.20
TRIB Important Levels
Resistance 2 5.70
Resistance 1 5.59
Pivot 5.41
Support 1 5.29
Support 2 5.18
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
DCTH 0.02 -33.33%
More..
NASDAQ USA Top Gainers Stocks
HMNY 3.81 55.51%
LOCM 0.09 50.00%
GSOL 17.88 49.00%
OPXAW 0.04 33.33%
WRES 0.09 28.57%
CGEI 0.28 27.27%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
BEBE 4.67 23.22%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
HAUP 0.07 -58.82%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Trinity Biotech plc (NASDAQ: TRIB)

TRIB Technical Analysis 4
As on 23rd May 2017 TRIB Share Price closed @ 5.44 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.19 & Sell for SHORT-TERM with Stoploss of 5.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
TRIB Target for May
1st Target up-side 6.17
2nd Target up-side 6.51
3rd Target up-side 6.84
1st Target down-side 5.21
2nd Target down-side 4.87
3rd Target down-side 4.54
TRIB Other Details
Segment EQ
Market Capital 303439360.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.trinitybiotech.com
TRIB Address
TRIB
IDA Business Park
Bray,
Ireland
Phone: 353 1 276 9800
Fax: 353 1 276 9888
TRIB Latest News
Trinity Biotech plc (ADR) (TRIB) Reaches $5.58 After 3.00% Up Move, 13 Bullish ...   Bibeypost.com   - 19th May 17
Goldman Capital Management Lowered Its Trinity Biotech (Trib) (TRIB) Position ...   Wolcott Daily   - 19th May 17
Trinity Biotech Announces Results for Q1, 2017   GlobeNewswire (press release)   - 27th Apr 17
Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results   GlobeNewswire (press release)   - 14th Mar 17
Trinity Biotech Plummets 50%: Here's What You Need To Know   Benzinga   - 04th Oct 16
Trinity Biotech plans to cut spending after withdrawal of device application ...   MarketWatch   - 04th Oct 16
Trinity Biotech plc Disappoints (TRIB)   Smarter Analyst   - 11th May 15
Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents   GlobeNewswire (press release)   - 30th Apr 15
News Trinity Biotech PLC ADRTRIB   Wall Street Journal   - 11th Feb 11
5.29   MarketWatch   - 07th Jul 09
Interactive Technical Analysis Chart Trinity Biotech plc ( TRIB NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Trinity Biotech plc
TRIB Business Profile
Trinity Biotech plc (Trinity Biotech)develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The Company is a provider of raw materials to the life sciences industry and research institutes globally through the Company subsidiary, Fitzgerald Industries. It markets its portfolio of over 275 products to customers in 75 countries around the world. It markets its products in the United States through a direct sales force and in the rest of the world through a combination of direct selling and a network of distributors. On July 26, 2013, it acquired Immco Diagnostics Inc.